Transcatheter closure of the atrial septal defect (ASD) resulted in significant reductions in tricuspid regurgitation (TR) and improvements in right ventricular dimensions, according to a new study in JACC: Cardiovascular Interventions.

A previously unknown gene-environment interaction between maternal diabetes and transcriptional regulator Notch1 raises the risk of congenital heart disease (CHD) in children, a paper published in the Journal of Clinical Investigation: Insight states.

Scientists have discovered a protein that appears to mimic the benefits of weight-loss surgery without requiring an operation.

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, highlights the largest endocarditis valve replacement study using CytoSorb published to date entitled, "Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass – a case series".

Just-released studies shine more positive light on TAVR in terms of durability five years out and long-term survival, with women outpacing men by about 15 percent.

Are enough resources available to treat the growing population of adults with congenital heart disease?   

Cardiovascular research has traditionally focused on hard clinical endpoints such as markers of disease progression, adverse events and death. But now researchers are calling for more studies that incorporate the viewpoints of patients and caregivers, both in trial design and execution and in measuring outcomes like quality of life, time off work, out-of-pocket expense and caregiver burden.

Women and minorities experience a higher risk of recurrent ischemic events than white men following everolimus-eluting stent implantation, a JAMA Cardiology study recently found.